CD4 and pneumocystosis: We anticipated prophylaxis may be warranted in patients receiving bendamustine based on the known prolonged effect of bendamustine on CD4+ counts; however, this known physiological effect did not result in high rates of PJP in our cohort of patients.15, 16, 18, 20